Amplia Therapeutics Health Care
Biotech Cancer Healthcare

$0.076 -0.001 (-1.30%)

High $0.08	Low $0.07	Trades 8	Turnover $9,058	Volume 120,981
30 June 2023 at 2:59pm

Market Cap (23-Oct) $41,064,960 (1,444th)	Close (30-Jun) $0.076 0 (0%)	Volume (30-Jun) 120,981	Shortsold (20-Oct) 30,144 (0.01%) (588th)
52w High $0.275	52w Low $0.076	P/E -	EPS -0.02

Short Interest

ASIC data, 20 Oct 2026

% Shorted

0.01%

vs 0.01% prior report

Most Shorted Rank

588th

of 709 shorted ASX stocks

Peak Short

0.23%

Nov 2024

Days to Cover

0.0

at 50d avg vol

View full short position history →

	Subject
	ATX ATX Ann: Application for quotation of securities - ATX
	1 (current) 2 3
	ATX ATX Ann: Annual General Meeting to be held Thursday 25 August 2022
	ATX ATX Ann: Registered Office and Principal Place of Business
	ATX ATX Ann: Notification of Expiry of Unlisted Options
	ATX ATX Ann: Application for quotation of securities - ATX
	ATX ATX Ann: AMP945 Shows Efficacy in Model of Lung Fibrosis
	ATX ATX Ann: App 4G - Key to Corporate Governance Disclosures
	ATX ATX Ann: 2022 Corporate Governance Statement
	ATX ATX Ann: Preliminary Final Report and Annual Report YE 31 March 2022
	ATX ATX Ann: Amplia Receives Second Ethics Clearance for Phase 2 Trial
	ATX ATX Ann: Amplia Presentation to 16th Bioshares Biotech Summit
	ATX ATX Ann: AMP945 Pre-IND Meeting Outcome
	ATX ATX Ann: Quarterly Activities and Cashflow Reports - March 2022 Qtr
	ATX ATX Ann: Ethics Clearance Phase 2 Trial - Pancreatic Cancer Patients
	ATX ATX Ann: Notification of cessation of securities - ATX
	ATX ATX Ann: AMP945 Improves Survival in Human Pancreatic Cancer Model
	ATX ATX Ann: ATX Abstract accepted for presentation at Cancer Conference
	ATX ATX Ann: Sale of Unmarketable Parcels of Shares
	ATX ATX Ann: Change of Director's Interest Notice - Jane Bell
	ATX ATX Ann: Amplia Investor Presentation - February 2022
	ATX ATX Ann: Quarterly Activities and Cashflow Reports - Dec 2021 Qtr
	ATX ATX Ann: Notification regarding unquoted securities - ATX
	ATX ATX Ann: Amplia Completes Manufacture of AMP945 for Planned Trials
	ATX ATX Ann: Change in substantial holding
	ATX ATX Ann: Application for quotation of securities - ATX
	ATX ATX Ann: Application for quotation of securities - ATX
	ATX ATX Ann: Change in substantial holding
	ATX ATX Ann: App 3Y - Change of Director's Interest - Mrs Jane Bell
	ATX ATX Ann: App 3Y - Change of Director's Interest - Dr. Chris Burns
	ATX ATX Ann: App 3Y - Change of Director's Interest - Dr. Robert Peach
	ATX ATX Ann: App 3Y - Change of Director's Interest - Dr. John Lambert
	ATX ATX Ann: App 3Y - Change of Directors Interest Notice - Dr. W. Tong
	ATX ATX Ann: Proposed issue of securities - ATX
	ATX ATX Ann: Update - Application for quotation of securities - ATX
	ATX ATX Ann: Results of Extraordinary General Meeting
	ATX ATX Ann: Amplia Provides Updated Investor Presentation
	ATX ATX Ann: Change in substantial holding
	ATX ATX Ann: Update - Application for quotation of securities - ATX
	ATX ATX Ann: Update - Proposed issue of securities - ATX
	ATX ATX Ann: Entitlement Offer Completed
	ATX ATX Ann: Amplia Awarded $2.1M R&D Cash Flow Loan
	ATX ATX Ann: App 4D and Financial Report Half Year ended 30 Sep 2021
	ATX ATX Ann: Notice of Extraordinary General Meeting - 17 Dec 2021
	ATX ATX Ann: Summary Results - Successful Phase 1 Clinical Trial AMP945
	ATX ATX Ann: Inhibition of FAK by AMP945 in Phase 1 Clinical Trial
	ATX ATX Ann: Becoming a substantial holder
	ATX ATX Ann: Application for quotation of securities - ATX
	ATX ATX Ann: Change in substantial holding
	ATX ATX Ann: Application for quotation of securities - ATX
	ATX ATX Ann: Section 708A Cleansing Notice - Share Placement

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
23-Oct	$0.08	1,180,858	+0.00 (2.56%)
22-Oct	$0.08	4,508,781	0.00 (3.70%)
21-Oct	$0.08	806,799	+0.00 (1.25%)
20-Oct	$0.08	610,183	0.00 (0.00%)
19-Oct	$0.08	1,877,590	0.00 (0.00%)
16-Oct	$0.08	13,952,546	-0.02 (20.00%)
15-Oct	$0.10	707,649	0.00 (0.00%)
14-Oct	$0.10	140,696	0.00 (0.00%)
13-Oct	$0.10	279,763	-0.01 (9.09%)
12-Oct	$0.11	314,427	+0.01 (4.76%)
09-Oct	$0.11	605,743	0.00 (0.00%)
08-Oct	$0.11	703,199	-0.01 (4.55%)
07-Oct	$0.11	132,574	-0.01 (4.35%)
06-Oct	$0.12	92,240	+0.01 (4.55%)
05-Oct	$0.11	28,310	0.00 (0.00%)
4 up, 5 down, and 6 flat days

Amplia Therapeutics Health Care
Biotech Cancer Healthcare

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Amplia Therapeutics Health Care Biotech Cancer Healthcare

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Amplia Therapeutics Health Care
Biotech Cancer Healthcare